Abstract:Introduction: Twist1, a basic helix‐loop‐helix (bHLH) transcription factor, has an important role in tumor biology by regulating epithelial‐mesenchymal transition. It also functions as a transcription repressor in NFκB‐dependent cytokine expression. Recently, we reported the identification and characterization of epithelial ovarian cancer (EOC) cells with stem‐like properties (Type I EOC cells). At the microRNA level, Type I EOC cells are characterized by low levels of hsa‐miR‐199a2 and hsa‐miR‐214. We also demonstrated the capacity of Type I EOC cells to differentiate into mature ovarian cancer cells (Type II EOC cells), which has lost stemness potential and express high levels of both hsa‐miR‐199a2 and hsa‐miR‐214. We also showed previously that hsa‐miR‐199a2 is able to regulate the levels of IKKβ and therefore have a direct effect on the NFκB pathway. Still, another group reported the regulatory control of hsa‐miR‐214 on the Akt pathway. In this study, we show that Twist1 is able to regulate the miR‐199a2/214 cluster in EOC cells and can therefore control both NFκB and Akt pathways. Methods: 5′‐RACE and 3′‐RACE was used to clone the full length pre‐miR‐199a gene. Real‐time PCR was used to determine the levels of Twist1 and miR‐199a2/214. Twist1 was knocked‐down in Type II EOC cells using siRNA. The effect of Twist1 knockdown on levels of IKKβ was determined by Western blot analysis. Cytokines were quantified using Luminex technology. Results: Characterization of full length of pre‐miR‐199a2 transcript reveals that the MIR199A2 gene contains a human microRNA cluster, miR‐199a2/214, and pre‐miR‐199a2 within the human Dnm3os gene (NCBI GeneID 474332). PCR analysis showed low levels of Twist1 and miR‐199a2/214 in Type I EOC cells but high levels of expression in Type II EOC cells. Knockdown of Twist1 in Type II cells induce a significant decrease in the levels both hsa‐miR‐199a2 and hsa‐miR‐214, and significant increase in IKKβ expression. Ectopic expression of hsa‐miR‐199a2 partially reverse the effect of Twist‐1 knockdown on the levels of IKKβ. The combination of knockdown Twist1 and TNFα stimulation in Type II EOC cells significantly increase Rantes, an NFκB‐dependent cytokine. Conclusion: We demonstrate for the first time that Twist1 plays a feedback role for the NFkB pathway by repressing IKKβ expression through hsa‐miR‐199a2. Twist1 inhibition of IKKβ expression through regulating hsa‐miR‐199a2, represents a novel negative feedback loop for the NFκB pathway. The demonstration that Twist1 can regulate the miR‐199a2/214 cluster and therefore both the IKKβ and Akt survival pathways, suggests the potential role of Twist1 in EOC differentiation. Furthermore it opens the opportunity to develop new approaches for targeting the ovarian cancer stem cells. Citation Information: Cancer Res 2009;69(23 Suppl):B75.

Research Progress of Twist Gene in Ovarian Cancer

Research progress between the embryo development gene Twist and gynecological tumor

Expression of Twist-1 promotes lymph node metastasis of gastric cancer cells

The expression of Twist and E -cadherin and its clinical significance in ovarian endometriosis

Relationship Between the Methylation Levels of Twist Gene and Pathogenesis of Endometriosis

Twist and Ovarian Cancer Stem Cells: Implications for Chemoresistance and Metastasis

Expression of signal transducer and activators of transcription 3 and Twist basic helix-loop-helix transcription factor 1 in epithelial ovarian cancer

Silencing of twist expression by RNA interference suppresses epithelial-mesenchymal transition, invasion, and metastasis of ovarian cancer.

Research Progress in Relationship between Survivin Gene and Ovarian Carcinoma

Twist2 promotes ovarian cancer cell survival through activation of Akt.

Expression of Twist in Cervical Cancer and Its Relationship with Clinical Biological Behaviors

Twist2 Contributes To Cisplatin-Resistance Of Ovarian Cancer Through The Akt/Gsk-3 Beta Signaling Pathway

Effect of Twist on Epithelial-mesenchymal Transitions in Ovarian Cancer Tissue

The Role of Nuclear Β-Catenin Accumulation in the Twist2-induced Ovarian Cancer EMT.

TWIST1 and Cancer

Expression and significance of twist and E-cadherin in ovarian cancer tissues.

Regulation of Gene Expression Profile by Twist in Murine Breast Cancer Cell

A Comprehensive Exploration of Twist1 to Identify a Biomarker for Tumor Immunity and Prognosis in Pan-Cancer

The Expression of Twist gene in Colorectal Carcinomals and relation with clinical pathological marker

Abstract B75: TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian Cancer Cells through MIR199A2/214

Expression and Significance of TWIST Basic Helix-Loop-helix Protein Over-Expression in Gastric Cancer.